'In Situ Simulation' Versus 'Off Site Simulation' in Obstetric Emergencies

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
Copenhagen Trial Unit, Center for Clinical Intervention Research
Information provided by (Responsible Party):
Jette Led Sorensen, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01792674
First received: January 30, 2013
Last updated: February 13, 2013
Last verified: February 2013
  Purpose

Care for pregnant is a field where unexpected emergencies occur, however emergencies are rare and hence competences difficult to learn. Therefore, it can be relevant to use simulation-based medical education. Many questions on how simulation can optimise learning remain unanswered. A major question is how simulation settings as 'in situ simulation' (i.e. in the actual patient care unit) versus 'off site simulation' (i.e. in training rooms or simulation center) impact learning.

Objectives: To study the effect of 'in situ simulation' versus 'off site simulation' on learning outcome, safety-attitudes, team performance and clinical performance in the simulated setting plus stress and motivational inducing effect of simulation settings.

Design: Randomised trial. Primary outcome: Written knowledge-test. Exploratory outcomes: Safety Attitudes Questionnaire, team- and clinical performance score, validated stress inventory, salivary cortisol, Intrinsic Motivation Inventory and questionnaire on perceptions of the simulation and organisational changes needed.

Perspective: To provide new knowledge on contextual effects of different simulation settings.


Condition Intervention
Education
Obstetrics
Simulation
'In Situ Simulation'
Other: In situ simulation
Other: Off site simulation

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Official Title: A Randomised Educational Feasibility Trial: 'In Situ Simulation' Versus 'Off Site Simulation' in Obstetric Emergencies and the Effect on Knowledge, Safety-attitudes, Team Performance, Stress, and Motivation

Further study details as provided by Rigshospitalet, Denmark:

Primary Outcome Measures:
  • Knowledge test by written test as multiple-choice questions (MCQ). [ Time Frame: The participants will get a knowledge test at the training day they will participate in. Ten training days will be conducted in a 3 months period ] [ Designated as safety issue: No ]
    The intervention will be applied on ten training days. Each training day will include training of one authentic team consisting of ten health care professionals.


Secondary Outcome Measures:
  • Exploratory outcomes: Safety Attitudes Questionnaire (SAQ). [ Time Frame: The participants will answer the Safety Attitudes Questionnaire (SAQ) 3-6 weeks before and 3-6 weeks after the training day they will participate in. Ten training days will be conducted in a 3 months period. ] [ Designated as safety issue: No ]
    Safety Attitudes Questionnaire (SAQ) is an inventory used in several countries. Safety Attitudes Questionnaire (SAQ) is an exploratory outcomes.

  • Exploratory outcomes: Team Emergency Assessment Measure (TEAM). [ Time Frame: Video's will be recorded at the ten training days (within a 3 months period) and within approximately 4 months after the video's will be assessed by independent observers. ] [ Designated as safety issue: No ]
    Team performance score measured by Team Emergency Assessment Measure (TEAM) will be assessed by independent observers by reviewing video recordings of the scenarios. A validated rating scale (Cooper S, 2010) will be used. Team Emergency Assessment Measure (TEAM) is an exploratory outcomes.

  • Exploratory outcomes: Video assessment: Clinical performance in the simulated setting. [ Time Frame: Video's will be recorded at the ten training days (within a 3 months period) and within approximately 4 months after be assessed by independent observers. ] [ Designated as safety issue: No ]
    Clinical performance in the simulated setting will be assessed by independent observers by reviewing video recordings of the simulations. The assessment will be based on international and national guidelines of best medical practice. Clinical performance in the simulated setting is an exploratory outcomes.

  • Exploratory outcome: Salivary cortisol [ Time Frame: Participants will have testing for salivary cortisol before and after the two simulated scenarios that will be conducted on the training they will participate in. ] [ Designated as safety issue: No ]
    Salivary cortisol is an exploratory outcome

  • Exploratory outcome: State-Trait Anxiety Inventory (STAI-1). [ Time Frame: Participants will respond on State-Trait Anxiety Inventory (STAI-1) before and after the two simulated scenarios that will be conducted on the training day they will participate in. ] [ Designated as safety issue: No ]
    State-Trait Anxiety Inventory (STAI-1) is a validated stress inventory. State-Trait Anxiety Inventory (STAI-1) is an exploratory outcome.

  • Exploratory outcome: Cognitive appraisal (CA). [ Time Frame: Participants will respond on cognitive appraisal (CA) before and after the two simulated scenarios that will be conducted on the training day they will participate in on one training day. ] [ Designated as safety issue: No ]
    Cognitive appraisal (CA) is applied on 10-point Likert scales to get information of the participants perceived stress of the upcoming event along with their capacity to cope with the stressor. Cognitive appraisal (CA) is an exploratory outcome.

  • Exploratory outcome: Intrinsic Motivation Inventory (IMI). [ Time Frame: The participants will answer on Intrinsic Motivation Inventory (IMI) approximately one week after the training day they will have participated in ] [ Designated as safety issue: No ]
    Intrinsic Motivation Inventory (IMI) is a validated inventory.Intrinsic Motivation Inventory (IMI) is an exploratory outcome.

  • Exploratory outcome: Participant's perceptions of the simulations. [ Time Frame: The participants will answer on questionnaires about their perceptions of the simulations approximately one week after the training day they will have participated in. ] [ Designated as safety issue: No ]
    Participant's perceptions of the simulations will be obtained on questionnaires including questions on Likert scales and few open questions about personal perceptions of the simulations and whether the simulations inspired to changes in the organisation.


Estimated Enrollment: 100
Study Start Date: April 2013
Estimated Study Completion Date: October 2013
Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: In situ simulation
'In situ simulation' which is training in the actual patient care unit, in this situation the labour suite and operation theatre
Other: In situ simulation
Active Comparator: Off site simulation
The control group will receive the same training 'off site simulation', i.e., in training rooms away from the actual patient care unit.
Other: Off site simulation

Detailed Description:

Background: Care for pregnant and delivering women is a field where unexpected emergencies, as for example emergency caesarean sectio, postpartum bleeding or severe preeclampsia, that may potentially harm both mother and baby, occur. Obstetric emergencies are rare and hence by nature difficult to learn in real life. Therefore, it can be relevant with simulation-based medical education, i.e., training with mannequins and scenarios. In non-systematic reviews it is concluded that repetitive medical simulations are associated with improved learner outcomes. However, many questions on how simulation can optimise learning in emergencies remain unanswered; e.g., how different kinds of simulation settings as 'in situ simulation' versus 'off site simulation' impact learning at the individual and the team level.

Objectives: In a randomised trial on authentic obstetric-anaesthesia teams to study the effect of 'in situ simulation' versus 'off site simulation' on participants learning outcome, safety-attitudes, team performance plus motivational and stress inducing effect of different simulation settings and the potential association with learning and performance.

Interventions: The experimental intervention is training in 'in situ simulation' which means training in the actual patient care unit, in this situation the labour suite and operation theatre. The control group will receive the same training 'off site simulation', i.e., in training rooms away from the actual patient care unit. In the two different simulation settings, the same scenarios will be conducted and the participants will comprise of authentic teams of specialised obstetricians or obstetric trainees in their final training year, trainee obstetricians, midwifes, auxiliary nurses, specialised anaesthetists or anaesthesia trainees in their final training year, trainee anaesthetists, anaesthesia nurses, and surgical nurses.

Design and trial size: Single-centre investigator-initiated randomised superiority trial. We have chosen to calculate the required sample size based on experiences about knowledge tests. We assume a standard deviation at 24%, and a difference in the experimental and control means at 17%. With alpha set at 0.05, beta set at 0.80 and intraclass correlation at 0,05 the sample size added up to 93 participants. It is planned to include 100 participants.

Outcomes: Primary outcome: 1) Knowledge by written test as multiple choice questions.

Exploratory outcomes: 1) Safety Attitudes Questionnaire SAQ). 2) Team performance score measured by Team Emergency Assessment Measure (TEAM). 3) Clinical performance in the simulated setting. 4) Salivary cortisol. 5) Validated stress inventory (Stress-Trait Anxiety Inventory (STAI-1) and cognitive appraisal). 6) Intrinsic Motivation Inventory (IMI). 7) Questionnaire to evaluate participants' perceptions of the simulation, the debriefing, and changes needed at the organisational level.

Time schedule: 2 years with start planning 1st of April 2012. Randomisation will start after approval from the Regional Ethics Committee and the Danish Data Protection Agency. The intervention with 'in situ simulation' versus 'on site simulation' described in this protocol will be scheduled spring 2013.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Health-care professionals (specialised obstetricians, trainee obstetricians, midwifes, auxiliary nurses, specialised anaesthetists, trainee anaesthetists, anaesthesia nurses, and surgical nurses) employed at the Obstetric or Anaesthesia departments at Rigshospitalet and trainee doctors having part of their training programme at Juliane Marie Centre for children, women and reproduction, Rigshospitalet.
  • Participants shall work in the evening-, night- and weekend-shift duties with some of their work in labour ward
  • Provide signed informed consent before randomisation

Exclusion Criteria:

  • Manager with staff responsibilities. Staff taking part in planning of the intervention.
  • Lack of informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01792674

Locations
Denmark
Rigshospitalet, Juliane Marie Centre for Children, Women and Reproduction
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Copenhagen Trial Unit, Center for Clinical Intervention Research
Investigators
Principal Investigator: Jette Led Sørensen, MD, MMEd Juliane Marie Centre for Children, Women and Reproduction , Rigshospitalet, Copenhagen University Hospital
  More Information

Additional Information:
No publications provided by Rigshospitalet, Denmark

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Jette Led Sorensen, MD, Consultant Obstetric Gynecologist, MMEd, Associate Professor, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT01792674     History of Changes
Other Study ID Numbers: ob-an-op-simulation-trial
Study First Received: January 30, 2013
Last Updated: February 13, 2013
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics
Denmark: Danish Dataprotection Agency

Keywords provided by Rigshospitalet, Denmark:
Education
Patient simulation
In situ simulation
Stress

Additional relevant MeSH terms:
Emergencies
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on April 17, 2014